Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani

British Journal of Clinical Pharmacology

Volumn 70, Issue 4, 2010, Pages 609-617

  Kumar, Awanish ^a   Sisodia, Brijesh ^b   Misra, Pragya ^a   Sundar, Shyam ^c   Shasany, Ajit Kumar ^b   Dube, Anuradha ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

2 DGE; Leishmania donovani; MALDI TOF MS; membrane enriched and cytosolic proteins; promastigotes; sodium antimony gluconate resistant clinical isolate

Indexed keywords

ABC TRANSPORTER; ANTIMONY GLUCONATE; CARBOXYPEPTIDASE; CELL NUCLEUS ANTIGEN; ENOLASE; FRUCTOSE 1,6 BISPHOSPHATE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 83; PROTEASOME; PROTEOME; PROTOZOAL PROTEIN; RIBOSOME PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ARTICLE; CYTOSOL; DRUG RESISTANCE; LEISHMANIA DONOVANI; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CYTOSOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS; MEMBRANE PROTEINS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77956577653     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03716.x     Document Type: Article

References (40)

1. Gazzinelli RT, Ropert C, Campos MA. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev 2004 201:9 25.
2. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PCK, Murray HW. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000 31:1104 1107.
3. Thakur CP, Narayan S, Ranjan A. Epidemiological, clinical and pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India. Indian J Med Res 2004 120:166 172.
4. Wyllie S, Cunningham ML, Fairlamb AH. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 2004 279:39925 39932.
5. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006 19:111 126.
6. Dube A, Singh N, Sundar S, Singh N. Refractoriness to the treatment of sodium stibogluconate in Indian Kala-Azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res 2005 96:216 223.
7. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 1998 19:837 844.
8. Pávková I, Hubálek M, Zechovská J, Lenco J, Stulík J. Francisella tularensis live vaccine strain: proteomic analysis of membrane proteins enriched fraction. Proteomics 2005 5:2460 2467.
9. Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: un amour impossible? Electrophoresis 2000 21:1054 1070.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193:265 275.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227:680 685.
12. Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998 14:378 379.
13. Gardy JL, Spencer C, Wang K, Ester M, Tusnady GE, Simon I, Hua S, deFays K, Lambert C, Nakai K, Brinkman FS. PSORT-B: improving protein subcellular localization prediction for Gram-negative bacteria. Nucleic Acids Res 2003 31:3613 3617.
14. McNicoll F, Drummelsmith J, Muller M, Madore E, Boilard N, Ouellette M, Papadopoulou B. A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics 2006 6:3567 3581.
15. Sinha S, Arora S, Kosalai K, Namane A, Pym AS, Cole ST. Proteome analysis of the plasma membrane of Mycobacterium tuberculosis. Comp Funct Genomics 2002 3:470 483.
16. Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M. A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 2007 6:88 101.
17. Kumar A, Boggula VR, Sundar S, Shasany AK, Dube A. Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP). Acta Trop 2009 110:80 5.
18. Jackson AP, Vaughan S, Gull K. Evolution of tubulin gene arrays in Trypanosomatid parasites: genomic restructuring in Leishmania. BMC Genomics 2006 7:261.
19. Santoni V, Kieffer S, Desclaux D, Masson F, Rabilloud T. Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties. Electrophoresis 2000 21:3329 3344.
20. Helling S, Schmitt E, Joppich C, Schulenborg T, Mullner S, Felske-Muller S, Wiebringhaus T, Becker G, Linsenmann G, Sitek B, Lutter P, Meyer HE, Marcus K. 2-D differential membrane proteome analysis of scarce protein samples. Proteomics 2006 6:4506 4513.
21. Kobe B, Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci 1994 19:415 421.
22. Castanys-Munoz E, Perez-Victoria JM, Gamarro F, Castanys S. Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement. Antimicrob Agents Chemother 2008 52:3573 3579.
23. Ouellette M, Legare D, Haimeur A, Grondin K, Roy G, Brochu C, Papadopoulou B. ABC transporters in Leishmania and their role in drug resistance. Drug Resist Updat 1998 1:43 8.
24. El Fadili K, Messier N, Leprohon P, Roy G, Guimond C, Trudel N, Saravia NG, Papadopoulou B, Légaré D, Ouellette M. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 2005 49:1988 1993.
25. Nagamune K, Ohishi K, Ashida H, Hong Y, Hino J, Kangawa K, Inoue N, Maeda Y, Kinoshita T. GPI transamidase of Trypanosoma brucei has two previously uncharacterized (trypanosomatid transamidase 1 and 2) and three common subunits. Proc Natl Acad Sci USA 2003 100:10682 10687.
26. Gonzalez AC, Thomas MC, Martinez-Carretero E, Carmelo E, Lopez MC, Valladares B. Molecular and immunological characterization of L14 ribosomal protein from Leishmania braziliensis. Parasitology 2004 128 (Pt 2 139 147. (Pubitemid 38283154)
27. Blachere NE, Li Z, Chandawarkar RY, Suto R, Jaikaria NS, Basu S, Udono H, Srivastava PK. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 1997 186:1315 1322.
28. Rico AI, Del Real G, Soto M, Quijada L, Martinez AC, Alonso C, Requena JM. Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun 1998 66:347 352.
29. Mozzetti S, Ferlini C, Concolino P, Filippetti F, Raspaglio G, Prislei S, Gallo D, Martinelli E, Ranelletti FO, Ferrandina G, Scambia G. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res 2005 11:298 305.
30. Isaza CE, Zhong X, Rosas LE, White JD, Chen RP, Liang GF, Chan SI, Satoskar AR, Chan MK. A proposed role for Leishmania major carboxypeptidase in peptide catabolism. Biochem Biophys Res Commun 2008 373:25 9.
31. Sundstrom P, Aliaga GR. A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase. J Infect Dis 1994 169:452 456.
32. McCarthy JS, Wieseman M, Tropea J, Kaslow D, Abraham D, Lustigman S, Tuan R, Guderian RH, Nutman TB. Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infect Immun 2002 70:851 858.
33. Selga E, Morales C, Noé V, Peinado MA, Ciudad CJ. Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells. BMC Medical Genomics 2008 1:35.
34. Mayer ATM, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993 71:2454 2460.
35. Wang CC, Bozdech Z, Liu CL, Shipway A, Backes BJ, Harris JL, Bogyo M. Biochemical analysis of the 20 S proteasome of Trypanosoma brucei. J Biol Chem 2003 278:15800 15808.
36. McConkey DJ, Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat 2008 11:164 179.
37. Cuervo P, de Jesus JB, Junqueira M, Mendonca-Lima L, Gonzalez LJ, Betancourt L, Grimaldi G Jr., Domonte GB, Fernandes O, Cupolillo E. Proteome analysis of Leishmania (Viannia) braziliensis by two-dimensional gel electrophoresis and mass spectrometry. Mol Biochem Parasitol 2007 154:6 21.
38. Kobe B, Deisenhofer J. Proteins with leucine-rich repeats. Curr Opin Struct Biol 1995 5:409 416.
39. BoseDasgupta S, Ganguly A, Roy A, Mukherjee T, Majumder HK. A novel ATP-binding cassette transporter, ABCG6 is involved in chemoresistance of Leishmania. Mol Biochem Parasitol 2008 158:176 188.
40. Gonzalez AC, Martinez E, Carmelo E, Pinero JE, Alonso V, Del Castillo A, Valladares B. Analysis of NLS and rRNA binding motifs in the L25 ribosomal protein from Leishmania (viannia) braziliensis: investigation of its diagnostic capabilities. Parasitology 2002 125 (Pt 1 51 7.